All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
COGNITION THERAPEUTICS INC Last Reported: 3/31/2024 Stock Symbol: CGTX

Business Address

2403 SIDNEY STREET
SUITE 261
PITTSBURGH , PA US 15203

Mailing Address

2500 WESTCHESTER AVE

PURCHASE , NY US 10577
Phone Number: 412-481-2210 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $32,969,000.00 $37,190,000.00 $41,562,000.00 $46,610,000.00 $45,771,000.00 $54,721,000.00 $8,300,000.00 -- -- $5,189,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $36,040,000.00 $41,551,000.00 $47,647,000.00 $50,932,000.00 $50,743,000.00 $58,992,000.00 $10,038,000.00 -- -- $6,908,000.00 -- -- -- --
Property Plant and Equipement $281,000.00 $248,000.00 $233,000.00 $246,000.00 $245,000.00 $145,000.00 $141,000.00 -- -- $211,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $38,772,000.00 $43,960,000.00 $50,425,000.00 $53,557,000.00 $52,812,000.00 $59,137,000.00 $13,389,000.00 -- -- $7,119,000.00 -- -- -- --
Accounts Payable $2,859,000.00 $4,060,000.00 $3,216,000.00 $8,087,000.00 $3,304,000.00 $4,168,000.00 $2,775,000.00 -- -- $2,003,000.00 -- -- -- --
Accrued Liabilities $4,288,000.00 $2,415,000.00 $2,094,000.00 $2,314,000.00 $1,667,000.00 $1,751,000.00 $740,000.00 -- -- $994,000.00 -- -- -- --
Total Current Liabilities $9,846,000.00 $9,574,000.00 $10,176,000.00 $14,237,000.00 $8,913,000.00 $7,864,000.00 $15,346,000.00 -- -- $19,933,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-196,000.00 $-196,000.00 $-199,000.00 $-201,000.00 $-200,000.00 $-198,000.00 $-196,000.00 -- -- $-187,000.00 -- -- -- --
Accumulated Deficit $-133,048,000.00 $-126,299,000.00 $-115,401,000.00 $-110,219,000.00 $-103,594,000.00 $-94,004,000.00 $-86,665,000.00 -- -- $-68,220,000.00 -- -- -- --
Total Stockholders' Equity $28,926,000.00 $34,386,000.00 $40,249,000.00 $39,320,000.00 $43,899,000.00 $51,273,000.00 $-86,718,000.00 $-83,682,000.00 $-67,854,000.00 $-68,184,000.00 $-66,489,000.00 $-64,508,000.00 $-61,970,000.00 $-58,422,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $38,772,000.00 $43,960,000.00 $50,425,000.00 $53,557,000.00 $52,812,000.00 $59,137,000.00 $13,389,000.00 -- -- $7,119,000.00 -- -- -- --

Statement of Operations

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $25,596,000.00 $8,497,000.00 $30,324,000.00 $8,268,000.00 $9,098,000.00 $18,572,000.00 $12,999,000.00 -- -- -- $3,399,000.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $35,535,000.00 $20,790,000.00 $43,551,000.00 $12,625,000.00 $12,213,000.00 $28,598,000.00 $16,790,000.00 -- -- -- $4,461,000.00 -- -- --
Loss from Operations $-35,535,000.00 $-11,817,000.00 $-43,551,000.00 $-34,251,000.00 $-12,213,000.00 $-28,598,000.00 $-16,790,000.00 -- -- -- $-13,287,000.00 -- -- --
Loss Before Income Taxes -- $-10,898,000.00 -- -- $-9,590,000.00 -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.59 $-0.37 $-0.91 $-0.29 $-0.43 $-3.13 $-8.12 -- -- -- $-18.34 -- -- --
Weighted Average Shares Basic 29,696,296 29,356,144 23,640,199 23,024,026 22,511,636 5,190,883 611,680 -- -- -- 498,415 -- -- --
Earnings Per Share Diluted $-0.22 $-0.16 $-0.91 $-0.71 $-0.43 $-3.13 $-8.12 -- -- -- $-5.31 -- -- --
Weighted Average Shares Diluted 29,696,296 29,614,822 23,640,199 22,684,309 22,595,359 5,190,883 611,680 -- -- -- 537,315 -- -- --
Common Stock Shares Authorized 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 70,000,000 -- -- 58,000,000 -- -- -- --
Common Stock Shares Outstanding 30,417,082 30,286,582 28,991,548 23,969,497 22,597,907 22,230,032 615,907 -- -- 538,793 -- -- -- --
Common Stock Value $30,000.00 $30,000.00 $29,000.00 $24,000.00 $22,000.00 $22,000.00 $1,000.00 -- -- $1,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- $1.20 -- -- --
Copyright 2024 PursePoor.com